Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Instalco expands in southern Sweden

Instalco continues its expansion in southern Sweden through the acquisition of Rörman i Svedala AB. Rörman is based in Svedala outside Malmö and is primarily active in heating and plumbing.Through the acquisition, Instalco strengthens its position within the heating and plumbing area in Skåne county, where the group’s subsidiary Rörläggaren also is located. Rörman was founded in 1979 and currently has 15 employees. Among its services, the company offers installations of geothermal heat pumps, air/water heat pumps and boilers. For the 2017/18 financial year, net sales amounted to

Scandion Oncology A/S approved for listing at Spotlight Stock Market

Today, Scandion Oncology A/S (“Scandion Oncology”) announces that the company has been approved for listing at Spotlight Stock Market (”Spotlight”). The approval is given under the condition that the company raises the minimum limit and that the company obtains a sufficient number of shareholders in accordance with Spotlight’s listing agreement in the upcoming IPO. The company plans to raise approximately 26 MSEK and the subscription period will run from October 4, 2018, to October 18, 2018, both dates inclusive. The company has secured pre-subscription of 18.5 MSEK, corresponding to

Phase I/II clinical study of MIV-818 started in patients with liver cancer

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the first patient has been enrolled and dosed with MIV-818 in a phase I/II study in patients with liver cancer. The purpose of this first-in-human trial is to study the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of MIV-818 in patients with advanced liver cancer. It will enroll patients with hepatocellular carcinoma (HCC), as well as patients with intrahepatic cholangiocarcinoma and patients with liver metastases from solid tumors. The design of phase I/II study of MIV-818 consists

#18-1765 Listing of Turbo warrants issued by BNP Paribas Issuance B.V.

As from October 02, 2018, 3 Turbo warrants issued by BNP Paribas Issuance B.V. will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: BNP Paribas Issuance B.V. Type of security: Call Turbo warrants of European type Execution: Automatic cash settlement Term: As from October 02, 2018 to expiry date Market Maker: BNP Paribas Arbitrage SNC Underlying: DAX 30 Index For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46

#18-1764 Listing of Mini futures issued by BNP Paribas Issuance B.V.

As from October 02, 2018, 25 Mini futures issued by BNP Paribas Issuance B.V. will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: BNP Paribas Issuance B.V. Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from October 02, 2018 and forward or until time for knock out event Market Maker: BNP Paribas Arbitrage SNC Underlying: Africa Oil Corporation Autoliv Inc SDB Avanza Bank Holding Boliden AB Genmab Hennes & Mauritz AB, H & M ser.

#18-1763 Listing of instrument issued by Skandinaviska Enskilda Banken AB

As from October 02, 2018, 1 instrument issued by Skandinaviska Enskilda Banken AB will be listed on NDX Miscellaneous Investment Products Sweden. The instrument will be registered at Euroclear Sweden AB.Issuer: Skandinaviska Enskilda Banken AB Agent: SEB For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The

#18-1762 Listing of Knock out warrants issued by Vontobel Financial Products GmbH

As from October 02, 2018, 9 Knock out warrants issued by Vontobel Financial Products GmbH will be listed on ETP Finland and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Finland Oy.Issuer: Vontobel Financial Products GmbH Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from October 02, 2018 and forward or until time for knock out event Market Maker: Bank Vontobel Europe AG Underlying: Facebook Inc Amazon.com Inc Apple Inc. DAX 30 Index Nokia Oyj Tesla Motors Inc.

#18-1761 Listing of Mini futures issued by Vontobel Financial Products GmbH

As from October 02, 2018, 9 Mini futures issued by Vontobel Financial Products GmbH will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: Vontobel Financial Products GmbH Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from October 02, 2018 and forward or until time for knock out event Market Maker: Bank Vontobel Europe AG Underlying: SNAP INC Tesla Motors Inc. Amazon.com Inc Gold (troy ounce) OMXS30 index Current values of

Telia Company invests in 5G frequencies in Finland

Telia Company invests in 5G frequencies in the 3.5 GHz band. The Ministry of Transport and Communications today announced the results of the license auction that started on September 26, 2018. Telia secured 130 MHz frequencies in the 3.5 GHz band.The new frequencies will enable the start of commercial 5G operations from the beginning of 2019. 5G is expected to improve the throughput of mobile networks by more than 20 times and the capacity up to hundred times compared to current networks. The revolutionary aspect is the ability to connect a huge number of devices connected to the network

Attana receives follow up contract research order from global pharma company

Attana has received a follow up contract research order from an global pharma company with headquarter in Europe. The contract is the results of the previous experiments and has an expanded range. The experiments are based on Attana’s patented cell-based biosensor and will included detailed interaction analysis between biopharmaceutical molecules and specific cells.Attana’s application specialists will perform experiments where the interactions between a specific target receptor in the cell membrane of three cell types and a number of different biopharmaceutical molecules with therapeutic

HEXPOL’s acquisition of 80 percent of the shares in MESGO Group, a notable Italian high performance elastomers compounder, is completed

HEXPOL has today completed the acquisition of 80 percent of the shares in MESGO Group from the existing main owner Mr. Francesco Caldara and co-owners. MESGO Group is an industry leader in high performance elastomers as fluorocarbons and silicone. In addition, MESGO also specializes in conventional rubber compounds and thermoplastics. The major customer segments MESGO focuses on are industry, consumer products, transportation and automotive. MESGO Group has an annual sale of around 100 MEUR with around 180 employees in six facilities. With this acquisition HEXPOL takes a strategic move

Correction: Elisa successful in the Finnish 3.5 Ghz 5G spectrum auction

ELISA STOCK EXCHANGE RELEASE 1 OCTOBER 2018 AT 2:07 PM The Finnish auction for the 3.5 GHz spectrum ended on 1 October 2018. Elisa won 130 MHz of spectrum according its target. The fee for the license is EUR 26.3 million and it will be paid in 5 annual installments. The license is valid from 1 January 2019 to 31 December 2033. Elisas current 4G network coverage is over 99.5 per cent. 5G services will  offer multiple data speeds, lower latency and various IoT functionalities. Elisa is a forerunner in developing 5G services, and has already built 5G ready mobile networks in the cites of

Alfa Laval’s Capital Markets Day, November 13

Alfa Laval invites analysts, professional investors and media to its capital markets day, which will be held on November 13, at Clarion Hotel Copenhagen Airport (previously Hilton), Denmark. It will start at 10:30 a.m. CET and end at approximately 16:30 CET.The morning session will include presentations by Tom Erixon, President and CEO, and Jan Allde, CFO. In the afternoon there will be parallel seminars, focusing on news and innovation concerning the offering in Energy, Food & Water and Marine. What are the advantages with the new platform for gasketed plate heat exchangers? For which

Vattenfall enters retail market in France

Vattenfall makes a first move to reach out to French households. Starting 1 October 2018, Vattenfall will offer retail customers climate-smart energy with the goal of helping them reduce their dependency on fossil fuels.Vattenfall has operated in France since 2000 and supplies more than 4,000 business customers with portfolio solutions and renewable energy. The company has earlier this year announced its participation in the tender for offshore wind outside Dunkirk. Vattenfall has a clear strategy to become fossil-free within one generation and wants to support its customers to do the same,

Proact secures place on Digital Outcomes and Specialists framework

Leading data centre and cloud service provider Proact has been selected to provide services as part of the Crown Commercial Service’s latest framework, Digital Outcomes and Specialists 3 (DOS3). Under the agreement, Proact will offer a range of enterprise-class services to public sector organisations across the United Kingdom, including 24/7 service management and security consultancy.Available on the Digital Marketplace from Monday 1st October, DOS3 aims to support the delivery of the Government Digital Strategy. By giving public sector buyers easy access to a large pool of suppliers with

Powerbox wins Power Product of the Year in recognition of its technical prowess in coreless power solution

Powerbox , one of Europe’s largest power supply companies with more than four decades as a leading force in optimizing power solutions for demanding applications, has won the Power Product of the Year accolade at the prestigious Electronics Industry Awards. Organized by Datateam Business Media in association with CIE magazine, the Electronics Industry Awards is designed to recognize the many successes in the electronics industry, celebrating outstanding companies, people and products. At a special awards ceremony in Birmingham on September 22, Powerbox’s Chief Marketing

Elisa successful in the Finnish 3.5 Ghz 5G spectrum auction

ELISA STOCK EXCHANGE RELEASE 1 OCTOBER 2018 AT 1:53 PM The Finnish auction for the 3.5 GHz spectrum ended on 1 October 2018. Elisa won 130 MHz of spectrum according its target. The fee for the license is EUR 23.6 million and it will be paid in 5 annual installments. The license is valid from 1 January 2019 to 31 December 2033. Elisas current 4G network coverage is over 99.5 per cent. 5G services will  offer multiple data speeds, lower latency and various IoT functionalities. Elisa is a forerunner in developing 5G services, and has already built 5G ready mobile networks in the cites of

Targovax presented ONCOS-102 poster at 13th International Adenovirus Meeting

Oslo, Norway, 1 October 2018: Targovax ASA (“Targovax” or “the Company”; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that the Company presented at the following conference:13th International Adenovirus MeetingDate: 27 September 2018Presenter: Lukasz Kuryk, Director Clinical SciencePoster session: 20:00 – 23:00  Venue: San José Vista Hermosa, MexicoAbstract title: “Anti-tumor specific T-cell responses induced by oncolytic adenovirus ONCOS-102 in peritoneal mesothelioma mouse model”Please see the poster

2018 Nobel Prize in Physiology or Medicine

jointly to                 James P. Allison and Tasuku Honjo             for their discovery of cancer therapy by inhibition of negative immune regulationSUMMARY Cancer kills millions of people every year and is one of humanity’s greatest health challenges. By stimulating the inherent ability of our immune system to attack tumor cells this year’s Nobel Laureates have established an entirely new principle for cancer therapy. James P. Allison studied a known protein that functions as a brake on the immune system. He realized the potential of releasing the brake and thereby

NCC to sell office project in Helsinki

NCC is selling its Fredriksberg office project in Helsinki for approximately SEK 460 million to Swiss Life Asset Managers. “In Fredriksberg, we developed a unique office project with a modern design, an interesting tenant mix and an attractive service offering. We are pleased that Swiss Life has chosen to invest in the project, which is located in one of Helsinki’s most attractive neighbourhoods,” says Petri Bergström, Head of NCC Property Development Finland. The project covers a total of approximately 9,000 square metres of lettable area for offices and retail, and is the

Read original

poLight ASA - Stabilisation and over-allotment notice

Oslo, 1 October 2018: Reference is made to the stock exchange notice published on 27 September 2018, in which poLight ASA ("poLight" or the "Company", OSE ticker: PLT) announced the successful completion of its initial public offering (the "Offering").ABG Sundal Collier ASA (the "Stabilisation Manager") may, on behalf of the Managers, engage in stabilisation activities of the shares of poLight (the "Shares") from today 1 October 2018 to and including 30 October 2018 (the "Stabilisation Period"). The stabilisation activities are aimed to support the market price of the Shares.In

Ciprofloxacin has dramatic effects on the mitochondrial genome — antibiotics should be used cautiously

Antibiotics have saved many lives by rescuing patients with bacterial or fungal infections, but these valuable drugs also have a dark side. As most medical drugs, also many antibiotics can have undesired effects on the body’s metabolism, causing more or less severe symptoms. The group of fluoroquinolones with its most famous member ciprofloxacin is such a case: Fluoroquinolones are some of the most frequently used broad-spectrum antibacterial antibiotics, and usually prescribed for respiratory, urinary or ear infections. While they are generally well tolerated, some patients receiving

Ahlstrom-Munksjö builds on its global platform for high-performance filtration material by completing the investment in Madisonville, U.S.

AHLSTROM-MUNKSJÖ OYJ, PRESS RELEASE, 1 October 2018 at 12.20 EET  As market demand for high-performance filtration material continue to increase globally, Ahlstrom-Munksjö continues to grow its attractive Filtration business and strengthens its manufacturing platform globally by completing a major investment in its plant in Madisonville, US. This EUR 23 million investment was announced in October 2016 and is one of several investments through which Ahlstrom-Munksjö has expanded its filtration manufacturing capabilities globally, in response to growing demand for high performance

Eva Nilsagård elected new IRRAS board member

Stockholm, Sweden, October 1, 2018 – The shareholders of IRRAS AB (“IRRAS”), a commercial-stage medical-technology company focused on developing and commercializing innovative solutions for various brain pathologies, voted to approve Eva Nilsagård as new member of the Group’s board of directors at today’s extraordinary shareholders’ meeting. Nilsagård has an impressive background in finance and business development, including Finance Manager at SKF AB, Senior Vice President of strategy and business development at Volvo AB and various finance rolls at Astra Tech, a former unit of

There are no items matching the current filter
There are no more items matching the current filter
Back to top